Neucure Lifesciences Private Limited
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Glimzab MV 2mg/500mg/0.3mg Tablet ER is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet ER
Glimzab MV 2mg/500mg/0.3mg Tablet ER is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimzab MV 2mg/500mg/0.3mg Tablet ER is to be taken empty stomach.
Glimzab MV 2mg/500mg/0.3mg Tablet ER is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimzab MV 2mg/500mg/0.3mg Tablet ER is a combination medicine that contains Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults by improving blood glucose levels when taken with proper diet and regular exercise.
Common side effects associated with the use of Glimzab MV 2mg/500mg/0.3mg Tablet ER include low blood sugar levels (hypoglycemia), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Glimzab MV 2mg/500mg/0.3mg Tablet ER should be avoided in patients with a known allergy to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
No, it is not safe to consume alcohol while taking Glimzab MV 2mg/500mg/0.3mg Tablet ER as it may lower blood sugar levels and increase the risk of lactic acidosis.
Yes, Glimzab MV 2mg/500mg/0.3mg Tablet ER can cause low blood sugar levels (hypoglycemia), which is more likely to occur if you miss or delay meals, consume alcohol, over-exercise, or take other antidiabetic medicines alongside it.
Store Glimzab MV 2mg/500mg/0.3mg Tablet ER in its original packet or container, tightly closed. Dispose of unused medicine properly to prevent accidental consumption by pets, children, and other individuals.